Cambiotics secures funding to initiate clinical trials and commercialize a dietary supplement for removing PFAS from the human body

Left to right: Peter Holme Jensen, Chief Executive Officer and Co-founder & Steen Dannemann Andersen, Chairman of the Board Copenhagen, Kingdom of Denmark – February 2nd, 2026 Cambiotics, a pioneering biotech company developing next-generation gut health solutions, has successfully closed a Seed…





